Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene-deficient mice independently of inhibition of lipid peroxidation in the artery wall

American Journal of Clinical Nutrition

Volumn 79, Issue 1, 2004, Pages 123-130

  Stocker, Roland ^a,b   O'Halloran, Ruth A ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Lipoprotein lipid oxidation; Mice; Polyphenols; Tocopheroxyl radicals; Vitamin E

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN; PHENOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; HYPERLIPOPROTEINEMIA TYPE 3; IN VITRO STUDY; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MORPHOMETRICS; MOUSE; NONHUMAN; OXIDATION; RED WINE;

EID: 2942564904     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/79.1.123     Document Type: Article

References (55)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
2. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000;28:1815-26.
3. Witztum JL, Steinberg D. The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc Med 2001;11:93-102.
4. Witting PK, Pettersson K, Östlund-Lindqvist A-M, Westerlund C, Wågberg M, Stocker R. Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in Watanabe heritable hyperlipidemic rabbits. J Clin Invest 1999;104:213-20.
5. Upston JM, Niu X, Brown AJ, et al. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am J Pathol 2002;160:701-10.
6. Mashima R, Witting PK, Stocker R. Oxidants and antioxidants in atherosclerosis. Curr Opin Lipidol 2001;12:411-8.
7. Kritharides L, Stocker R. The use of antioxidant supplements in coronary heart disease. Atherosclerosis 2002;164:211-9.
8. Bowry VW, Stocker R. Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993;115:6029-44.
9. 10 inhibits atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol 2001;21:585-93.
10. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev 1993;15:328-51.
11. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-6.
12. Rudel LL, Leathers CW, Bond MG, Bullock BC. Dietary ethanol-induced modifications in hyperlipoproteinemia and atherosclerosis in nonhuman primates (Macaca nemestrina). Arteriosclerosis 1981;1:144-55.
13. Shaish A, Pape M, Rea T, et al. Alcohol increases plasma levels of cholesterol diet-induced atherogenic lipoproteins and aortic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol 1997;17:1091-7.
14. Emeson EE, Manaves V, Singer T, Tabesh M. Chronic alcohol feeding inhibits atherogenesis in C57BL/6 hyperlipidemic mice. Am J Pathol 1995;147:1749-58.
15. Meagher EA, Barry OP, Burke A, et al. Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 1999;104:805-13.
16. Willett WC, Sacks F, Trichopoulous A, et al. The Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995;61(suppl):1402S-6S.
17. Halliwell B, Aeschbach R, Loliger J, Aruoma OI. The characterization of antioxidants. Food Chem Toxicol 1995;33:601-17.
18. Hertog MGL, Kronhout D, Aravanis C, et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 1995;155:381-6.
19. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-7.
20. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
21. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56.
22. Iijima K, Yoshizumi M, Hashimoto M, et al. Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene. Circulation 2000;101:805-11.
23. Leikert JF, Rathel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002;106:1614-7.
24. Wallerath T, Deckert G, Ternes T, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002;106:1652-8.
25. Abu-Amsha Caccetta R, Burke V, Mori TA, Beilin LJ, Puddey IB, Croft KD. Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects. Free Radic Biol Med 2001;30:636-42.
26. Hayek T, Fuhrman B, Vaya J, et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 1997;17:2744-52.
27. Munday JS, Thompson KG, James KA, Manktelow BW. The effect of moderate alcohol consumption as either red or white wine in the C57BL/6 mouse atherosclerosis model. Coron Artery Dis 1999;10:97-102.
28. da Luz PL, Serrano CV Jr, Chacra AP, et al. The effect of red wine on experimental atherosclerosis: lipid-independent protection. Exp Mol Pathol 1999;65:150-9.
29. Bentzon JF, Skovenborg E, Hansen C, et al. Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice. Circulation 2001;103:1681-7.
30. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. Apo-E deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-40.
31. Suarna C, Hood RL, Dean RT, Stocker R. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim Biophys Acta 1993;1166:163-70.
32. Witting PK, Mohr D, Stocker R. Assessment of pro- and anti-oxidant activity of vitamin E in human low density lipoprotein and plasma. Methods Enzymol 1999;299:362-75.
33. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem 1986;157:106-16.
34. Rieger T. Spinning cone: a tool to remove alcohol and sulfites. Vineyard Winery Manage 1994;20:29-31.
35. Oszmianski J, Ramos T, Bourzeix M. Fractionation of phenolic compounds in red wine. Am J Enol Vitic 1988;39:259-62.
36. Singleton VL, Rossi JA. Colorimetry of total phenols with phosphomolybdic-phosphotungstic acid reagents. Am J Enol Vitic 1965;16: 144-58.
37. Witting PK, Westerlund C, Stocker R. A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids. J Lipid Res 1996;37:853-67.
38. Buettner GR. In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals. J Biochem Biophys Methods 1988;16:27-40.
39. Behrens WA, Madere R. A highly sensitive high-performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in tissues, biological fluids, and foods. Anal Biochem 1987;165:102-7.
40. Bowry VW, Mohr D, Cleary J, Stocker R. Prevention of tocopherol-mediated peroxidation of ubiquinol-10-free human low density lipoprotein. J Biol Chem 1995;270:5756-63.
41. Letters JM, Witting PK, Christison JK, Eriksson AW, Pettersson K, Stocker R. Changes to lipids and antioxidants in plasma and aortae of apoE-deficient mice. J Lipid Res 1999;40:1104-12.
42. Sattler W, Mohr D, Stocker R. Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence. Methods Enzymol 1994;233:469-89.
43. Barclay LRC, Locke SJ, MacNeil JM, VanKessel J. Autoxidation of micelles and model membranes. Quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants. J Am Chem Soc 1984;106:2479-81.
44. 10 in apolipoprotein E gene knockout mice. Free Radic Biol Med 2000;29:295-305.
45. Witting PK, Pettersson K, Letters J, Stocker R. Site-specific anti-atherogenic effect of probucol in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 2000;20:e26-33.
46. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998;394:200-3.
47. Neuzil J, Christison JK, Iheanacho E, et al. Radical-induced lipoprotein and plasma lipid oxidation in normal and apolipoprotein E gene knockout (apoE-/-) mice. ApoE-/- mouse as a model for testing the role of tocopherol-mediated peroxidation in atherogenesis. J Lipid Res 1998;39:354-68.
48. Patel RP, Boersma BJ, Crawford JH, et al. Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Radic Biol Med 2001;31:1570-81.
49. Upston JM, Terentis AC, Morris K, Keaney JF Jr, Stocker R. Oxidized lipid accumulates in the presence of α-tocopherol in atherosclerosis. Biochem Genet 2002;363:753-60.
50. Terentis AC, Thomas SR, Burr JA, Liebler DC, Stocker R. Vitamin E oxidation in human atherosclerotic lesions. Circ Res 2002;90:333-9.
51. Witting PK, Pettersson K, Östlund-Lindqvist A-M, Westerlund C, Westin Eriksson A, Stocker R. Inhibition by a co-antioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J 1999;13:667-75.
52. Fruebis J, Bird DA, Pattison J, Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Res 1997;38:2455-64.
53. Upston JM, Witting PK, Brown AJ, Stocker R, Keaney JF Jr. Effect of vitamin E on aortic lipid oxidation and intimai proliferation after vascular injury in cholesterol-fed rabbits. Free Radic Biol Med 2001; 31:1245-53.
54. Waddington E, Puddey IB, Croft KD. Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation. Am J Clin Nutr 2004;79: 54-61.
55. 2α-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E. Blood 2001;97:459-64.